What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging?

European Radiology

Volumn 26, Issue 4, 2016, Pages 1098-1107

  De Visschere, Pieter Julien Luc ^a   Naesens, Leslie ^a   Libbrecht, Louis ^a   Van Praet, Charles ^a   Lumen, Nicolaas ^a   Fonteyne, Valérie ^a   Pattyn, Eva ^a   Villeirs, Geert ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Diffusion magnetic resonance imaging; Magnetic resonance imaging; Magnetic resonance spectroscopy; Prostate; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SIZE; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE VOLUME; PROSTATECTOMY; RADIODIAGNOSIS; TRANSRECTAL ULTRASONOGRAPHY; BIOPSY; CANCER GRADING; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; PROSTATE; PROSTATE TUMOR; REPRODUCIBILITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 84934783278     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-015-3894-x     Document Type: Article

References (34)

1. Barentsz JO, Richenberg J, Clements R, et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22(4):746–757
2. de Rooij M, Hamoen EH, Fütterer JJ, et al (2014) Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. Am J Roentgenol 202(2):343–351
3. Kumar V, Jagannathan NR, Thulkar S, et al (2012) Prebiopsy magnetic resonance spectroscopy and imaging in the diagnosis of prostate cancer. Int J Urol 19(7):602–613
4. Thompson JE, Moses D, Shnier R, et al (2014) Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection:a prospective study. J Urol 192(1):67–74
5. Kirkham AP, Emberton M, Allen C (2006) How good is MRI at detecting and characterising cancer within the prostate? Eur Urol 50(6):1163–1174, discussion 1175
6. Delongchamps NB, Rouanne M, Flam T, et al (2011) Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int 107(9):1411–1418
7. Villeirs GM, Oosterlinck W, Vanherreweghe E, et al (2010) A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer. Eur J Radiol 73(2):352–356
8. Arumainayagam N, Ahmed HU, Moore CM, et al (2013) Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard. Radiology 268(3):761–769
9. Itatani R, Namimoto T, Atsuji S, et al (2014) Negative predictive value of multiparametric MRI for prostate cancer detection: outcome of 5-year follow-up in men with negative findings on initial MRI studies. Eur J Radiol 83(10):1740–1745
10. Pokorny MR, De Rooij M, Duncan E, et al (2014) Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 66(1):22–29
11. Bird RE, Wallace TW, Yankaskas BC (1992) Analysis of cancers missed at screening mammography. Radiology 184(3):613–617
12. Kurhanewicz J, Vigneron DB, Hricak H, et al (1996) Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology 198(3):795–805
13. Villeirs GM, De Meerleer GO, De Visschere PJL, et al (2011) Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients. Eur J Radiol 77(2):340–345
14. Epstein JI, Allsbrook WC Jr, Amin MB, et al (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29(9):1228–1242
15. Kumar R, Nayyar R, Kumar V, et al (2008) Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study. Urology 72(4):859–863
16. Numao N, Yoshida S, Komai Y, et al (2013) Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer. J Urol 190(2):502–508
17. Yerram NK, Volkin D, Turkbey B, et al (2012) Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int 110(11 Pt B):E783–8
18. Bratan F, Niaf E, Melodelima C, et al (2013) Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI:a prospective study. Eur Radiol 23(7):2019–2029
19. Rosenkrantz AB, Mendrinos S, Babb JS, et al (2012) Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected. J Urol 187(6):2032–2038
20. Langer DL, van der Kwast TH, Evans AJ, et al (2008) Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. Radiology 249(3):900–908
21. Ellis JH, Tempany C, Sarin MS, et al (1994) MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis. Am J Roentgenol 162(4):865–872
22. Klotz L (2013) Active surveillance:patient selection. Curr Opin Urol 23(3):239–244
23. Wolters T, Roobol MJ, Van Leeuwen PJ, et al (2011) A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. J Urol 185(1):121–125
24. Epstein JI, Lieberman PH (1985) Mucinous adenocarcinoma of the prostate gland. Am J Surg Pathol 9(4):299–308
25. Humphrey PA (2012) Histological variants of prostatic carcinoma and their significance. Histopathology 60(1):59–74
26. Westphalen AC, Coakley FV, Kurhanewicz J, et al (2009) Mucinous adenocarcinoma of the prostate: MRI and MR spectroscopy features. Am J Roentgenol 193(3):W238–W243
27. Outwater E, Schiebler ML, Tomaszewski JE, et al (1992) Mucinous carcinomas involving the prostate:atypical findings at MR imaging. J Magn Reson Imaging 2(5):597–600
28. Shimizu T, Nischie A, Ro T, et al (2009) Prostate cancer detection: the value of performing an MRI before a biopsy. Acta Radiol 50(9):1080–1088
29. Stamey TA, Freiha FS, McNeal JE, et al (1993) Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 71(3 Suppl):933–938
30. Ploussard G, Epstein JI, Montironi R, et al (2011) The contemporary concept of significant versus insignificant prostate cancer. Eur Urol 60(2):291–303
31. Ahmed HU, Kirkham A, Arya M, et al (2009) Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol 6(4):197–206
32. Le JD, Tan N, Shkolyar E, et al (2015) Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging:correlation with whole-mount histopathology. Eur Urol 67(3):569–576
33. De Visschere P, Oosterlinck W, De Meerleer G, et al (2010) Clinical and imaging tools in the early diagnosis of prostate cancer, a review. JBR-BTR 93(2):62–70
34. Rabbani F, Stroumbakis N, Kava BR, et al (1998) Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol 159(4):1247–1250